Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
182.44
-3.15 (-1.70%)
Mar 3, 2025, 4:00 PM EST - Market closed
Inspire Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 802.8 | 624.8 | 407.86 | 233.39 | 115.38 | Upgrade
|
| Revenue Growth (YoY) | 28.49% | 53.19% | 74.75% | 102.28% | 40.62% | Upgrade
|
| Cost of Revenue | 122.99 | 96.58 | 66.12 | 33.28 | 17.62 | Upgrade
|
| Gross Profit | 679.82 | 528.22 | 341.74 | 200.12 | 97.76 | Upgrade
|
| Selling, General & Admin | 529.61 | 451.96 | 320.69 | 202.62 | 127.87 | Upgrade
|
| Research & Development | 114.13 | 116.54 | 68.65 | 37.35 | 26.09 | Upgrade
|
| Operating Expenses | 643.74 | 568.49 | 389.33 | 239.97 | 153.97 | Upgrade
|
| Operating Income | 36.08 | -40.27 | -47.59 | -39.85 | -56.21 | Upgrade
|
| Interest Expense | -0.02 | - | -1.68 | -2.13 | -2.12 | Upgrade
|
| Interest & Investment Income | 23.25 | 20.56 | 5.05 | 0.13 | 1.09 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.9 | -0.2 | -0.1 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.05 | 0.01 | 0.05 | -0.12 | 0.15 | Upgrade
|
| Pretax Income | 58.45 | -19.91 | -44.27 | -41.97 | -57.09 | Upgrade
|
| Income Tax Expense | 4.94 | 1.25 | 0.61 | 0.07 | 0.12 | Upgrade
|
| Earnings From Continuing Operations | 53.51 | -21.15 | -44.88 | -42.04 | -57.2 | Upgrade
|
| Net Income | 53.51 | -21.15 | -44.88 | -42.04 | -57.2 | Upgrade
|
| Net Income to Common | 53.51 | -21.15 | -44.88 | -42.04 | -57.2 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 29 | 28 | 27 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 29 | 28 | 27 | 26 | Upgrade
|
| Shares Change (YoY) | 4.24% | 4.38% | 2.97% | 4.56% | 9.53% | Upgrade
|
| EPS (Basic) | 1.80 | -0.72 | -1.60 | -1.54 | -2.19 | Upgrade
|
| EPS (Diluted) | 1.75 | -0.72 | -1.60 | -1.54 | -2.19 | Upgrade
|
| Free Cash Flow | 91.12 | 1.02 | 2.47 | -24.79 | -55.5 | Upgrade
|
| Free Cash Flow Per Share | 2.98 | 0.03 | 0.09 | -0.91 | -2.13 | Upgrade
|
| Gross Margin | 84.68% | 84.54% | 83.79% | 85.74% | 84.73% | Upgrade
|
| Operating Margin | 4.49% | -6.45% | -11.67% | -17.07% | -48.72% | Upgrade
|
| Profit Margin | 6.67% | -3.39% | -11.00% | -18.01% | -49.58% | Upgrade
|
| Free Cash Flow Margin | 11.35% | 0.16% | 0.61% | -10.62% | -48.10% | Upgrade
|
| EBITDA | 42.63 | -37.43 | -45.73 | -38.63 | -55.37 | Upgrade
|
| EBITDA Margin | 5.31% | -5.99% | -11.21% | -16.55% | -47.99% | Upgrade
|
| D&A For EBITDA | 6.55 | 2.85 | 1.86 | 1.22 | 0.84 | Upgrade
|
| EBIT | 36.08 | -40.27 | -47.59 | -39.85 | -56.21 | Upgrade
|
| EBIT Margin | 4.49% | -6.45% | -11.67% | -17.07% | -48.72% | Upgrade
|
| Effective Tax Rate | 8.46% | - | - | - | - | Upgrade
|
| Advertising Expenses | 94.9 | 100.3 | 74.3 | 47.8 | 26.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.